Data / Form D filings / KAZIA THERAPEUTICS LTD
KAZIA THERAPEUTICS LTD: Form D filings
KAZIA THERAPEUTICS LTD, a biotechnology company in Sydney Nsw, Australia, filed 4 Form D notices with the SEC between 2023 and 2025. The latest, on December 18, 2025, reports $55.3 million sold of a $55.3 million offering to 65 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, Sydney Nsw, Australia, 2000
- Phone
- 01161298780088
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Australia
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1075880
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | New notice | $55,251,088 | $55,251,088 | 65 | Dec 3, 2025 | sec.gov | |
| Aug 14, 2025 | New notice | $2,050,013 | $2,050,013 | 4 | Aug 4, 2025 | sec.gov | |
| Jan 17, 2025 | New notice | $2,060,000 | $2,060,000 | 1 | Jan 10, 2025 | sec.gov | |
| Dec 15, 2023 | New notice | $2,000,000 | $2,000,000 | 1 | Dec 5, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elissa Hansen | Executive Officer | |
| Ebru Davidson | Director | |
| Steven Coffey | Director | |
| Bryce Carmine | Director | |
| Jeffrey Bonacorda | Executive Officer | |
| John Friend | Executive Officer | |
| Robert Apple | Director |
Every Form D from the week of Dec 15, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what KAZIA THERAPEUTICS LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.